Fingerprint
Dive into the research topics of 'All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
Meletios A. Dimopoulos, Sebastian Grosicki, Wiesław W. Jędrzejczak, Hareth Nahi, Astrid Gruber, Markus Hansson, Neeraj Gupta, Catriona Byrne, Richard Labotka, Zhaoyang Teng, Huyuan Yang, Norbert Grzasko, Shaji Kumar
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations